{"hands_on_practices": [{"introduction": "A central goal in systems biology is to understand what governs the abundance of molecules within a cell. This practice begins with the most fundamental model for noncoding RNA dynamics, treating cellular concentration as a balance between synthesis and degradation. By deriving the solution to a simple linear ordinary differential equation, you will learn to quantify the crucial parameter of RNA half-life ($t_{1/2}$) from experimental data, providing a direct link between a mathematical description and a measurable biological property [@problem_id:4370156].", "problem": "In systems biomedicine, modeling the dynamics of noncoding ribonucleic acid (ncRNA) abundance connects molecular synthesis and turnover to measurable time courses. Consider a single ncRNA species in a homogeneous cell population. Assume a well-mixed compartment, no feedback on transcription within the short observation window, and that synthesis and decay are memoryless (Poisson) processes, so that a mass-balance at the level of abundance $A(t)$ is appropriate.\n\nStarting from fundamental principles that abundance changes equal the net balance of synthesis and removal, derive a kinetic model for $A(t)$ in which synthesis occurs at a constant rate $k_{s}$ and removal (degradation) occurs with first-order kinetics at rate constant $\\gamma$. Show how this model predicts the time evolution of $A(t)$ both under ongoing transcription and following acute transcriptional inhibition. Define the half-life $t_{1/2}$ as the time required for $A(t)$ to decrease from its initial value $A(0)$ to $A(0)/2$ under transcriptional inhibition.\n\nNow, consider an enhancer RNA (eRNA) measured by high-throughput sequencing in a human cell line. At time $t=0$, transcription is acutely inhibited (e.g., by actinomycin D), so that synthesis ceases immediately. The measured normalized abundances are $A(0)=800$ (arbitrary normalized units) and $A(120)=200$ at $t=120$ minutes after inhibition. Using only the modeling assumptions outlined above, compute the half-life $t_{1/2}$ for this eRNA.\n\nRound your answer to four significant figures and express the final time in minutes.\n\nAs part of your derivation, state clearly the modeling assumptions that are expected to hold for different ncRNA classes, including microRNA (miRNA) and long noncoding RNA (lncRNA), and justify when first-order removal and constant effective synthesis are reasonable approximations for these classes within short observational windows.", "solution": "The problem asks for the derivation of a kinetic model for noncoding ribonucleic acid (ncRNA) abundance, its application to a specific experimental scenario, and a discussion of the underlying assumptions. The validation of the problem statement is the mandatory first step.\n\n**Problem Validation**\n\n**Step 1: Extract Givens**\n-   The system is a single ncRNA species in a homogeneous cell population, modeled as a well-mixed compartment.\n-   The abundance of the ncRNA is denoted by $A(t)$.\n-   Synthesis and decay are memoryless (Poisson) processes.\n-   Synthesis occurs at a constant rate $k_s$.\n-   Removal (degradation) follows first-order kinetics with a rate constant $\\gamma$.\n-   The fundamental principle is that the rate of change of abundance is the net balance of synthesis and removal.\n-   Transcriptional inhibition is an acute process that sets synthesis to zero ($k_s=0$).\n-   Half-life, $t_{1/2}$, is defined as the time for abundance to decrease from $A(0)$ to $\\frac{A(0)}{2}$ under transcriptional inhibition.\n-   Experimental data for an enhancer RNA (eRNA) under transcriptional inhibition:\n    -   $A(0) = 800$ (arbitrary normalized units) at $t=0$ minutes.\n    -   $A(120) = 200$ at $t=120$ minutes.\n-   The final answer for the half-life must be in minutes and rounded to four significant figures.\n-   A discussion is required on the validity of the assumptions for different ncRNA classes (miRNA, lncRNA).\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientifically Grounded:** The problem is based on the standard and widely accepted mass-action kinetics model for RNA turnover, a cornerstone of molecular systems biology. The model's components—constant synthesis and first-order decay—and the experimental context (transcriptional inhibition using agents like actinomycin D) are scientifically sound and standard practice.\n-   **Well-Posed:** The problem is well-posed. It provides a clear theoretical framework and sufficient data ($A(0)$ and $A(120)$) to uniquely determine the single unknown parameter ($\\gamma$) of the decay process, which in turn uniquely determines the half-life ($t_{1/2}$).\n-   **Objective:** The problem is stated in precise, objective, and quantitative terms. It is free from ambiguity and subjective claims.\n-   **Completeness and Consistency:** The problem is self-contained and internally consistent. It provides all necessary definitions, assumptions, and data required for the solution.\n-   **Realism and Feasibility:** The data provided ($A(0)=800$, $A(120)=200$) are plausible for an unstable RNA species like an eRNA, and the timeframe is realistic for such an experiment.\n\n**Step 3: Verdict and Action**\nThe problem is valid as it is scientifically sound, well-posed, objective, and complete. I will now proceed with the solution.\n\n**Model Derivation and Solution**\n\nThe fundamental principle stated is that the time rate of change of abundance, $\\frac{dA(t)}{dt}$, is the difference between the rate of synthesis and the rate of removal.\n$$\n\\frac{dA(t)}{dt} = (\\text{Rate of Synthesis}) - (\\text{Rate of Removal})\n$$\nAccording to the problem, synthesis occurs at a constant rate $k_s$, and removal is a first-order process with rate constant $\\gamma$, meaning its rate is proportional to the current abundance $A(t)$. Substituting these into the balance equation gives the governing ordinary differential equation (ODE):\n$$\n\\frac{dA(t)}{dt} = k_s - \\gamma A(t)\n$$\nThis is a first-order linear inhomogeneous ordinary differential equation.\n\n**Time Evolution Under Ongoing Transcription**\nTo find the time evolution with ongoing transcription ($k_s > 0$), we solve the full ODE. The solution is the sum of the homogeneous solution and a particular solution. The homogeneous equation is $\\frac{dA_h}{dt} = -\\gamma A_h$, which solves to $A_h(t) = C \\exp(-\\gamma t)$ for some constant $C$. For a particular solution, we can assume a steady state where $\\frac{dA}{dt} = 0$. This gives $0 = k_s - \\gamma A_{ss}$, so the steady-state abundance is $A_{ss} = \\frac{k_s}{\\gamma}$.\nThe general solution is $A(t) = C \\exp(-\\gamma t) + A_{ss}$. Using the initial condition $A(0)$, we find $C = A(0) - A_{ss}$.\nThus, the time evolution is given by:\n$$\nA(t) = A_{ss} + (A(0) - A_{ss}) \\exp(-\\gamma t) = \\frac{k_s}{\\gamma} + \\left(A(0) - \\frac{k_s}{\\gamma}\\right) \\exp(-\\gamma t)\n$$\nThis equation describes the abundance $A(t)$ approaching its steady-state value $A_{ss}$ from an initial value $A(0)$.\n\n**Time Evolution Following Transcriptional Inhibition**\nWhen transcription is acutely inhibited at time $t=0$, the synthesis rate $k_s$ immediately becomes $0$. The ODE simplifies to:\n$$\n\\frac{dA(t)}{dt} = - \\gamma A(t)\n$$\nThis is a first-order linear homogeneous ODE. We can solve it by separation of variables:\n$$\n\\frac{dA}{A} = -\\gamma dt\n$$\nIntegrating from the initial time $t=0$ with abundance $A(0)$ to a later time $t$ with abundance $A(t)$:\n$$\n\\int_{A(0)}^{A(t)} \\frac{1}{A'} dA' = \\int_{0}^{t} -\\gamma dt'\n$$\n$$\n\\ln(A(t)) - \\ln(A(0)) = -\\gamma t\n$$\n$$\n\\ln\\left(\\frac{A(t)}{A(0)}\\right) = -\\gamma t\n$$\nExponentiating both sides yields the solution for the decay process:\n$$\nA(t) = A(0) \\exp(-\\gamma t)\n$$\n\n**Half-Life Definition and Calculation**\nThe half-life, $t_{1/2}$, is defined as the time at which the abundance has fallen to half of its initial value, i.e., $A(t_{1/2}) = \\frac{A(0)}{2}$. Substituting this into the decay equation:\n$$\n\\frac{A(0)}{2} = A(0) \\exp(-\\gamma t_{1/2})\n$$\nDividing by $A(0)$ (assuming $A(0) \\neq 0$):\n$$\n\\frac{1}{2} = \\exp(-\\gamma t_{1/2})\n$$\nTaking the natural logarithm of both sides:\n$$\n\\ln\\left(\\frac{1}{2}\\right) = -\\gamma t_{1/2}\n$$\n$$\n-\\ln(2) = -\\gamma t_{1/2}\n$$\nSolving for $t_{1/2}$ gives its fundamental relationship with the decay rate constant $\\gamma$:\n$$\nt_{1/2} = \\frac{\\ln(2)}{\\gamma}\n$$\n\n**Computation for the eRNA**\nWe are given the experimental data following transcriptional inhibition: $A(0) = 800$ and $A(120) = 200$, where time is in minutes. We use the decay equation $A(t) = A(0) \\exp(-\\gamma t)$ to find the value of $\\gamma$.\n$$\n200 = 800 \\exp(-\\gamma \\cdot 120)\n$$\n$$\n\\frac{200}{800} = \\frac{1}{4} = \\exp(-120\\gamma)\n$$\nTaking the natural logarithm:\n$$\n\\ln\\left(\\frac{1}{4}\\right) = -120\\gamma\n$$\n$$\n-\\ln(4) = -120\\gamma\n$$\nUsing the logarithm property $\\ln(x^y) = y \\ln(x)$, we have $\\ln(4) = \\ln(2^2) = 2\\ln(2)$.\n$$\n-2\\ln(2) = -120\\gamma\n$$\nSolving for $\\gamma$:\n$$\n\\gamma = \\frac{2\\ln(2)}{120} = \\frac{\\ln(2)}{60} \\text{ min}^{-1}\n$$\nNow we can compute the half-life $t_{1/2}$ using the derived formula:\n$$\nt_{1/2} = \\frac{\\ln(2)}{\\gamma} = \\frac{\\ln(2)}{\\frac{\\ln(2)}{60}} = 60 \\text{ minutes}\n$$\nThe problem requires the answer to be rounded to four significant figures. Since the result is an exact integer, expressing it with four significant figures gives $60.00$.\n\n**Discussion of Modeling Assumptions**\nThe applicability of this model rests on the assumptions of constant effective synthesis ($k_s$) and first-order removal ($\\gamma A(t)$).\n-   **Constant Synthesis Rate ($k_s$):** This assumption holds reasonably well for many ncRNAs when a cell population is in a steady physiological state. For regulated ncRNAs like lncRNAs and miRNAs involved in dynamic processes (e.g., cell cycle, differentiation, stress response), transcription rates are variable. However, for a *short observational window* where the cellular state is not perturbed (other than by the transcription inhibitor itself), $k_s$ can be considered constant, representing the pre-inhibition transcriptional output. For population-level measurements, stochastic transcriptional bursting in individual cells averages out, making a constant effective rate a good approximation.\n-   **First-Order Removal:** This implies that each RNA molecule has an independent and constant probability per unit time of being degraded. This is biochemically equivalent to the degradation machinery (e.g., ribonucleases, RISC for miRNAs) not being saturated by its substrate. For most ncRNAs, including eRNAs, lncRNAs, and miRNA precursors, cellular concentrations are typically low enough for this to be a valid assumption. These molecules are often rapidly turned over by efficient enzymatic pathways. Deviations could occur for extremely abundant and stable RNAs or if degradation is a complex, multi-step process. Mature miRNAs, once loaded into the Argonaute protein to form the RISC, are often exceptionally stable, and their turnover can be linked to target interaction rather than simple first-order decay, making this model less suitable for the mature functional form but still applicable to their precursors (pri- and pre-miRNAs). For unstable species like eRNAs and many lncRNAs, first-order decay is an excellent and widely confirmed model.", "answer": "$$\\boxed{60.00}$$", "id": "4370156"}, {"introduction": "The journey of many ncRNAs involves trafficking between cellular compartments, a process critical for their function. This exercise moves beyond simple decay to model the active transport of a primary microRNA from the nucleus to the cytoplasm, a process mediated by transport proteins like Exportin-5. You will apply the principles of Michaelis-Menten kinetics to derive the rate of this saturable process, translating abstract kinetic parameters into a tangible molecular flux of exported ncRNAs per second [@problem_id:4370124].", "problem": "A single-cell model considers the nuclear export of primary microRNA (pri-microRNA) by Exportin-5 (also known as Exportin-5:Ran guanosine triphosphate (RanGTP) complex) as a saturable, enzyme-like transport process. Let the nuclear concentration of pri-microRNA substrate be $[S]$, the concentration of free transporter be $[E]$, the concentration of transporter–substrate complex be $[ES]$, and the total transporter concentration be $[E_T] = [E] + [ES]$. The minimal reaction scheme is\n$$\nE + S \\xrightleftharpoons[k_{-1}]{k_1} ES \\xrightarrow{k_{\\mathrm{cat}}} E + S_{\\mathrm{cyto}},\n$$\nwhere $k_1$ is the association rate constant, $k_{-1}$ is the dissociation rate constant, and $k_{\\mathrm{cat}}$ is the catalytic export rate constant. Assume a well-mixed nucleus and that the RanGTP cofactor is abundant and constant, such that the transporter cycle can be modeled by the above scheme without explicit cofactor dynamics.\n\nStarting from the law of mass action and the quasi-steady-state approximation for $[ES]$ in the regime where the substrate is not significantly depleted by complex formation, derive the concentration flux of export $v$ (with units of concentration per time) as a function of $[S]$ and the kinetic parameters. Then express your result in terms of the standard measurable constants $K_m$ and $V_{\\max}$ used to summarize this class of transport processes, and evaluate the flux for the following measured values at physiological conditions:\n- $K_m = 50\\,\\mathrm{nM}$,\n- $V_{\\max} = 120\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$,\n- nuclear pri-microRNA concentration $[S] = 25\\,\\mathrm{nM}$.\n\nFinally, convert the concentration flux into a molecular export flux (molecules per second per nucleus) for a nucleus of volume $V_{\\mathrm{nuc}} = 500\\,\\mathrm{fL}$ using Avogadro’s constant $N_A = 6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1}$. State and justify the biophysical conditions under which the derived rate law is expected to be accurate for Exportin-5–mediated nuclear export in living cells. Express the final flux in molecules per second and round your answer to $3$ significant figures.", "solution": "The problem requires the derivation and application of a rate law for a saturable transport process, modeled using principles of enzyme kinetics. The process is the nuclear export of primary microRNA (pri-microRNA) mediated by the transporter Exportin-5. We will first validate the problem statement.\n\n### Step 1: Extract Givens\n-   **Model**: Single-cell model of nuclear export of pri-microRNA by Exportin-5.\n-   **Process Type**: Saturable, enzyme-like transport.\n-   **Species**: $S$ (nuclear pri-microRNA substrate), $E$ (free transporter, Exportin-5:RanGTP), $ES$ (transporter-substrate complex), $S_{\\mathrm{cyto}}$ (cytoplasmic pri-microRNA).\n-   **Concentrations**: $[S]$, $[E]$, $[ES]$, $[E_T]$.\n-   **Constraint**: Total transporter concentration is $[E_T] = [E] + [ES]$.\n-   **Reaction Scheme**: $E + S \\xrightleftharpoons[k_{-1}]{k_1} ES \\xrightarrow{k_{\\mathrm{cat}}} E + S_{\\mathrm{cyto}}$\n-   **Rate Constants**: $k_1$ (association), $k_{-1}$ (dissociation), $k_{\\mathrm{cat}}$ (catalytic export).\n-   **Key Assumptions**: Well-mixed nucleus; abundant and constant RanGTP cofactor; substrate not significantly depleted.\n-   **Approximation**: Quasi-steady-state approximation (QSSA) for $[ES]$.\n-   **Objectives**:\n    1.  Derive the concentration flux $v$ as a function of $[S]$, $k_1$, $k_{-1}$, and $k_{\\mathrm{cat}}$.\n    2.  Express the result in terms of the Michaelis constant $K_m$ and maximum flux $V_{\\max}$.\n    3.  Evaluate $v$ for $K_m = 50\\,\\mathrm{nM}$, $V_{\\max} = 120\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$, and $[S] = 25\\,\\mathrm{nM}$.\n    4.  Convert $v$ to a molecular export flux (molecules per second) for a nucleus with volume $V_{\\mathrm{nuc}} = 500\\,\\mathrm{fL}$, using Avogadro's constant $N_A = 6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1}$.\n    5.  State and justify the biophysical conditions under which the derived rate law is accurate.\n-   **Final Answer Format**: Round the final flux to $3$ significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. It applies the standard Michaelis-Menten kinetic model, a fundamental concept in biochemistry, to the process of nucleocytoplasmic transport, a common and valid approach in systems biology. The reaction scheme is a correct simplification for this type of analysis. The problem is well-posed, providing all necessary constants, variables, and assumptions to arrive at a unique solution. The language is objective and precise. The provided numerical values—$K_m$ in the nanomolar range, a nuclear volume in femtoliters—are physiologically plausible. The problem does not violate any fundamental principles, is not incomplete or contradictory, and is directly relevant to the specified fields.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. A rigorous solution will be developed.\n\n### Derivation of the Rate Law\nThe rate of change of the transporter-substrate complex concentration, $[ES]$, is described by the law of mass action applied to the reaction scheme $E + S \\xrightleftharpoons[k_{-1}]{k_1} ES \\xrightarrow{k_{\\mathrm{cat}}} E + S_{\\mathrm{cyto}}$. The rate equation for $[ES]$ is:\n$$\n\\frac{d[ES]}{dt} = k_1 [E][S] - (k_{-1} + k_{\\mathrm{cat}})[ES]\n$$\nThe first term on the right-hand side represents the formation of the complex from free transporter $E$ and substrate $S$. The second term represents the breakdown of the complex, either by dissociation back to $E$ and $S$ (rate constant $k_{-1}$) or by catalytic export to release $E$ and cytoplasmic product $S_{\\mathrm{cyto}}$ (rate constant $k_{\\mathrm{cat}}$).\n\nWe apply the quasi-steady-state approximation (QSSA), which assumes that the concentration of the intermediate complex $[ES]$ equilibrates rapidly and remains approximately constant on the timescale of substrate consumption and product formation. Therefore, we set $\\frac{d[ES]}{dt} = 0$:\n$$\nk_1 [E][S] = (k_{-1} + k_{\\mathrm{cat}})[ES]\n$$\nThe total concentration of the transporter is conserved: $[E_T] = [E] + [ES]$. We can express the free transporter concentration as $[E] = [E_T] - [ES]$. Substituting this into the steady-state equation:\n$$\nk_1 ([E_T] - [ES])[S] = (k_{-1} + k_{\\mathrm{cat}})[ES]\n$$\nWe now solve for $[ES]$:\n$$\nk_1 [E_T][S] - k_1 [ES][S] = (k_{-1} + k_{\\mathrm{cat}})[ES]\n$$\n$$\nk_1 [E_T][S] = (k_{-1} + k_{\\mathrm{cat}} + k_1 [S])[ES]\n$$\n$$\n[ES] = \\frac{k_1 [E_T][S]}{k_{-1} + k_{\\mathrm{cat}} + k_1 [S]}\n$$\nTo simplify, we divide the numerator and denominator by $k_1$:\n$$\n[ES] = \\frac{[E_T][S]}{\\frac{k_{-1} + k_{\\mathrm{cat}}}{k_1} + [S]}\n$$\nThe concentration flux of export, $v$, is the rate of formation of the exported product, $S_{\\mathrm{cyto}}$. According to the reaction scheme, this is determined by the catalytic step:\n$$\nv = k_{\\mathrm{cat}}[ES]\n$$\nSubstituting the derived expression for $[ES]$, we find the flux as a function of $[S]$ and the kinetic parameters:\n$$\nv = \\frac{k_{\\mathrm{cat}}[E_T][S]}{\\frac{k_{-1} + k_{\\mathrm{cat}}}{k_1} + [S]}\n$$\n\n### Expression in Terms of $K_m$ and $V_{\\max}$\nThis expression can be simplified by defining two standard macroscopic parameters.\nThe Michaelis constant, $K_m$, is defined as:\n$$\nK_m = \\frac{k_{-1} + k_{\\mathrm{cat}}}{k_1}\n$$\n$K_m$ has units of concentration and represents the substrate concentration at which the reaction rate is half of the maximum.\n\nThe maximum flux, $V_{\\max}$, is the rate achieved when the transporter is fully saturated with substrate (i.e., when $[S] \\to \\infty$, all transporter is in the complex form, $[ES] \\to [E_T]$). The flux is then $v \\to k_{\\mathrm{cat}}[E_T]$. Thus, we define:\n$$\nV_{\\max} = k_{\\mathrm{cat}}[E_T]\n$$\nSubstituting these two definitions, $K_m$ and $V_{\\max}$, into the derived flux equation yields the familiar Michaelis-Menten form:\n$$\nv = \\frac{V_{\\max}[S]}{K_m + [S]}\n$$\n\n### Numerical Evaluation and Conversion to Molecular Flux\nWe are given the following physiological values:\n-   $K_m = 50\\,\\mathrm{nM}$\n-   $V_{\\max} = 120\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$\n-   $[S] = 25\\,\\mathrm{nM}$\n\nFirst, we calculate the concentration flux $v$:\n$$\nv = \\frac{(120\\,\\mathrm{nM}\\,\\mathrm{min}^{-1})(25\\,\\mathrm{nM})}{50\\,\\mathrm{nM} + 25\\,\\mathrm{nM}} = \\frac{3000}{75}\\,\\mathrm{nM}\\,\\mathrm{min}^{-1} = 40\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}\n$$\nNext, we convert this concentration flux into a molecular flux ($\\Phi$, in units of molecules per second). This requires converting units and accounting for the nuclear volume.\n\nThe concentration flux is $v = 40\\,\\mathrm{nM}\\,\\mathrm{min}^{-1}$. Let's convert this to SI-based units of $\\mathrm{mol}\\,\\mathrm{L}^{-1}\\,\\mathrm{s}^{-1}$:\n$$\nv = 40\\,\\frac{\\mathrm{nmol}}{\\mathrm{L} \\cdot \\mathrm{min}} \\times \\frac{1\\,\\mathrm{min}}{60\\,\\mathrm{s}} \\times \\frac{10^{-9}\\,\\mathrm{mol}}{1\\,\\mathrm{nmol}} = \\frac{2}{3} \\times 10^{-9}\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}\\,\\mathrm{s}^{-1}\n$$\nThe rate of change of the number of moles of substrate being exported from the nucleus is the concentration flux multiplied by the nuclear volume, $\\frac{dn}{dt} = v \\cdot V_{\\mathrm{nuc}}$. The given nuclear volume is $V_{\\mathrm{nuc}} = 500\\,\\mathrm{fL}$. We convert this to liters:\n$$\nV_{\\mathrm{nuc}} = 500\\,\\mathrm{fL} \\times \\frac{10^{-15}\\,\\mathrm{L}}{1\\,\\mathrm{fL}} = 5 \\times 10^{-13}\\,\\mathrm{L}\n$$\nNow, we can find the molar flux:\n$$\n\\frac{dn}{dt} = \\left(\\frac{2}{3} \\times 10^{-9}\\,\\frac{\\mathrm{mol}}{\\mathrm{L} \\cdot \\mathrm{s}}\\right) \\times (5 \\times 10^{-13}\\,\\mathrm{L}) = \\frac{10}{3} \\times 10^{-22}\\,\\frac{\\mathrm{mol}}{\\mathrm{s}}\n$$\nTo find the molecular flux $\\Phi$, we multiply the molar flux by Avogadro's constant, $N_A = 6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1}$:\n$$\n\\Phi = \\frac{dn}{dt} \\times N_A = \\left(\\frac{10}{3} \\times 10^{-22}\\,\\mathrm{mol}\\,\\mathrm{s}^{-1}\\right) \\times (6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1})\n$$\n$$\n\\Phi = \\frac{10 \\times 6.022}{3} \\times 10^{(-22+23)}\\,\\mathrm{s}^{-1} = \\frac{60.22}{3} \\times 10^{1}\\,\\mathrm{s}^{-1} = 20.0733... \\times 10\\,\\mathrm{s}^{-1} = 200.733...\\,\\mathrm{s}^{-1}\n$$\nRounding to $3$ significant figures, the molecular export flux is $201\\,\\text{molecules per second}$.\n\n### Biophysical Conditions for Model Accuracy\nThe accuracy of the derived Michaelis-Menten rate law for describing pri-microRNA export in a living cell depends on the validity of its underlying assumptions:\n1.  **Quasi-Steady-State Approximation (QSSA)**: The assumption that $\\frac{d[ES]}{dt} \\approx 0$ is valid if the total transporter concentration $[E_T]$ is much smaller than the sum of the substrate concentration and the Michaelis constant, i.e., $[E_T] \\ll K_m + [S]$. This ensures that the concentration of the $[ES]$ complex adjusts much more rapidly than the concentrations of $[S]$ and $[S]_{\\mathrm{cyto}}$. In the cell, this means the pool of available Exportin-5 must be small enough that it reaches a steady-state of binding and unbinding on a timescale faster than the overall rate of pri-microRNA production and clearance.\n\n2.  **Constant Substrate Concentration**: The derivation assumes $[S]$ is constant, which is classic for measuring initial reaction rates. For the model to hold in a dynamic cellular steady-state, the rate of pri-microRNA synthesis (transcription) must balance the rate of its removal (export and any nuclear degradation). If the export flux $v$ is a significant fraction of the total flux through the pri-microRNA pool, then $[S]$ will change over time, and a more complex dynamic model including a synthesis term would be necessary for long-term prediction.\n\n3.  **Well-Mixed Nucleus**: The model assumes spatial homogeneity, ignoring diffusion times and potential sub-nuclear compartmentalization. This assumption holds if the diffusion of pri-microRNA and Exportin-5 is fast compared to the rates of their association and subsequent export. In the viscous and crowded nucleoplasm, molecular movement can be hindered, and if transcription sites are localized, concentration gradients could form, violating this assumption.\n\n4.  **Non-limiting Cofactors (RanGTP)**: The model abstracts away the Ran cycle by assuming the active form of the transporter, Exportin-5:RanGTP, is always available and its concentration is effectively subsumed into $[E]$. This requires that the nuclear concentration of RanGTP is high and that the machinery for regenerating RanGTP from RanGDP (the RanGEF, RCC1) is not rate-limiting. This is generally considered to be the case under normal physiological conditions, as the Ran system serves many transport pathways simultaneously.\n\n5.  **Irreversibility of Export**: The model assumes the step $ES \\xrightarrow{k_{\\mathrm{cat}}} E + S_{\\mathrm{cyto}}$ is irreversible. In the cell, the export directionality is maintained by the steep concentration gradient of RanGTP (high in the nucleus) versus RanGDP (high in the cytoplasm). The release of cargo in the cytoplasm is coupled to GTP hydrolysis by Ran, an energetically favorable process that renders the overall export cycle effectively irreversible. Furthermore, rapid cytoplasmic processing of pri-microRNA by the Dicer enzyme prevents product accumulation, thus precluding product inhibition or back-transport.", "answer": "$$\n\\boxed{201}\n$$", "id": "4370124"}, {"introduction": "Beyond their own life cycles, ncRNAs exert their influence by interacting with other molecules in complex regulatory networks. This final practice explores the function of circular RNAs (circRNAs) as 'sponges' that sequester microRNAs (miRNAs), thereby modulating their activity. Starting from the law of mass action, you will derive the equilibrium state of this interaction to produce a quantitative model of miRNA sequestration, a cornerstone of understanding competing endogenous RNA (ceRNA) networks [@problem_id:4370186].", "problem": "A single circular RNA (circRNA) species with cellular concentration $C$ (molar units) contains $N$ identical microRNA (miRNA) binding sites. Consider one miRNA species with total cellular concentration $M_{\\mathrm{tot}}$ (molar units). Each site binds one miRNA with dissociation constant $K_d$ (molar units), defined at equilibrium by the Law of Mass Action as $K_d = \\frac{[\\mathrm{miRNA}]_{\\mathrm{free}} \\,[\\mathrm{site}]_{\\mathrm{free}}}{[\\mathrm{site}\\cdot \\mathrm{miRNA}]}$. Assume independent, noncooperative binding across sites and a 1:1 stoichiometry per site. Derive, from first principles, an explicit closed-form expression for the equilibrium miRNA sequestration capacity (the concentration of miRNA bound to the circRNA) and the equilibrium free miRNA concentration, in terms of $N$, $K_d$, $C$, and $M_{\\mathrm{tot}}$. Use conservation of mass for miRNA and the definition of $K_d$ as foundational starting points. Provide your final answer as a row matrix whose first entry is the bound miRNA concentration and whose second entry is the free miRNA concentration. All concentrations are in molar units. No numerical values are provided, and no rounding is required.", "solution": "Let $x$ denote the equilibrium free miRNA concentration, $x = [\\mathrm{miRNA}]_{\\mathrm{free}}$. By the definition of the dissociation constant and the Law of Mass Action for a single site,\n$$\nK_d = \\frac{x\\,[\\mathrm{site}]_{\\mathrm{free}}}{[\\mathrm{site}\\cdot \\mathrm{miRNA}]}\n$$\nFor an independent, identical site, the fraction of sites occupied by miRNA, denoted $f$, is given by the Langmuir isotherm derived from the above definition:\n$$\nf = \\frac{[\\mathrm{site}\\cdot \\mathrm{miRNA}]}{[\\mathrm{site}]_{\\mathrm{free}} + [\\mathrm{site}\\cdot \\mathrm{miRNA}]} = \\frac{x}{K_d + x}\n$$\nSince there are $N$ sites per circRNA and a circRNA concentration $C$, the total concentration of occupied sites (which equals the concentration of miRNA bound to circRNA due to $1:1$ stoichiometry per site) is $B$:\n$$\nB = N\\,C\\,f = N\\,C\\,\\frac{x}{K_d + x}\n$$\nConservation of mass for miRNA requires that\n$$\nM_{\\mathrm{tot}} = x + B = x + N\\,C\\,\\frac{x}{K_d + x}\n$$\nWe therefore obtain an equation for $x$:\n$$\nx + N\\,C\\,\\frac{x}{K_d + x} = M_{\\mathrm{tot}}\n$$\nMultiplying both sides by $K_d + x$ yields\n$$\nx(K_d + x) + N\\,C\\,x = M_{\\mathrm{tot}}(K_d + x)\n$$\nwhich expands to\n$$\nx^2 + xK_d + N\\,C\\,x = M_{\\mathrm{tot}}K_d + M_{\\mathrm{tot}}x\n$$\nCollecting terms into a standard quadratic form in $x$ gives\n$$\nx^2 + x\\big(K_d + N\\,C - M_{\\mathrm{tot}}\\big) - M_{\\mathrm{tot}}K_d = 0\n$$\nDefine $b \\equiv K_d + N\\,C - M_{\\mathrm{tot}}$ for brevity. The discriminant is\n$$\n\\Delta = b^2 + 4\\,M_{\\mathrm{tot}}\\,K_d > 0\n$$\nand the quadratic formula yields two roots:\n$$\nx = \\frac{-b \\pm \\sqrt{b^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n$$\nBecause $\\sqrt{b^2 + 4\\,M_{\\mathrm{tot}}\\,K_d} > |b|$, the root with the negative sign produces $x<0$, which is nonphysical for a concentration. Therefore the physically admissible solution is\n$$\nx = \\frac{-b + \\sqrt{b^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2} = \\frac{-(K_d + N\\,C - M_{\\mathrm{tot}}) + \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n$$\nThe equilibrium bound miRNA concentration $B$ can be expressed either as $N\\,C\\,\\frac{x}{K_d + x}$ or, more simply, by conservation of mass as $B = M_{\\mathrm{tot}} - x$. Substituting the expression for $x$ and simplifying gives\n$$\nB = M_{\\mathrm{tot}} - \\frac{-(K_d + N\\,C - M_{\\mathrm{tot}}) + \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n=\n\\frac{M_{\\mathrm{tot}} + K_d + N\\,C - \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n$$\nThus, the equilibrium miRNA sequestration capacity (bound concentration) and the equilibrium free miRNA concentration are\n$$\nB = \\frac{M_{\\mathrm{tot}} + K_d + N\\,C - \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n$$\n$$\nx = \\frac{-(K_d + N\\,C - M_{\\mathrm{tot}}) + \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^2 + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n$$\nThese expressions satisfy both mass-action equilibrium and conservation of mass and reduce to the expected limits: when $N\\,C \\to 0$, $B \\to 0$ and $x \\to M_{\\mathrm{tot}}$; when $K_d \\to 0$ with finite $N\\,C$, binding saturates up to $B \\to \\min\\{M_{\\mathrm{tot}}, N\\,C\\}$, and $x$ adjusts accordingly via the quadratic solution.", "answer": "$$\\boxed{\\begin{pmatrix}\n\\frac{M_{\\mathrm{tot}} + K_d + N\\,C - \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^{2} + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2} & \\frac{-(K_d + N\\,C - M_{\\mathrm{tot}}) + \\sqrt{(K_d + N\\,C - M_{\\mathrm{tot}})^{2} + 4\\,M_{\\mathrm{tot}}\\,K_d}}{2}\n\\end{pmatrix}}$$", "id": "4370186"}]}